These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37729)

  • 21. Rat strain differences in brain monoamine metabolism following para-chlorophenylalanine treatment.
    Emery D; Engel J; Larsson K
    Pharmacol Biochem Behav; 1980 Feb; 12(2):311-2. PubMed ID: 6445566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of adrenocorticotrophin-(4-10)-heptapeptide on changes in brain monamine metabolism associated with retrograde amnesia in the rat.
    Leonard BE; Ramaekers F; Rigter H
    Biochem Soc Trans; 1975; 3(1):113-5. PubMed ID: 165102
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of a butyrophenone derivative, U-32,802A, on brain biogenic amines.
    Lahti RA; Lednicer D
    Biochem Pharmacol; 1974 Jun; 23(12):1701-5. PubMed ID: 4842658
    [No Abstract]   [Full Text] [Related]  

  • 24. Antagonism of the acute electroencephalographic and behavioral effects of morphine in the rat by depletion of brain biogenic amines.
    Colasanti B; Khazan N
    Neuropharmacology; 1973 May; 12(5):463-9. PubMed ID: 4267733
    [No Abstract]   [Full Text] [Related]  

  • 25. The inhibition of monoamine uptake into rat brain synaptosomess by selected bicyclo-octanes and an analogous bicyclo-octene.
    Wedley S; Howard JL; Large BT; Pullar IA
    Biochem Pharmacol; 1978; 27(24):2907-9. PubMed ID: 736983
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of pentoxifylline and aminophylline on biogenic amine metabolism of the rat brain.
    Cardinali DP
    Eur J Pharmacol; 1978 Jan; 47(2):239-43. PubMed ID: 620686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Central monoaminergic mechanisms and generalized convulsions (review)].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):457-63. PubMed ID: 817551
    [No Abstract]   [Full Text] [Related]  

  • 28. An interaction of histamine H2-receptor antagonists with the noradrenergic system in rat brain.
    Nowak JZ; Pilc A; Maśliński C
    Eur J Pharmacol; 1978 Sep; 51(1):71-5. PubMed ID: 29763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse.
    Wenger GR; Stitzel RE; Craig CR
    Neuropharmacology; 1973 Jul; 12(7):693-703. PubMed ID: 4147164
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biogenic monoamines and their precursors in rats with spontaneous arterial hypertension].
    Kaliman PA; Sergienko NG; Luchko NA; Brovina NN
    Vopr Med Khim; 1983; 29(2):69-73. PubMed ID: 6858037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of an anti-atherosclerotic drug, pyridinolcarbamate, on heart, vascular and brain biogenic amines.
    Berkowitz BA; Hidaka H; Spector S
    Br J Pharmacol; 1973 May; 48(1):179-81. PubMed ID: 4724191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoaminergic structures of the hypothalamus under chronic stress conditions.
    Konstantinova MS; Smorodina IP
    Neurosci Behav Physiol; 1986; 16(6):513-6. PubMed ID: 3822089
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
    Symchowicz S; Korduba CA; Veals J
    Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
    [No Abstract]   [Full Text] [Related]  

  • 34. Developmental characteristics of central monoamine neurons and their reciprocal relations.
    Jonsson G
    Exp Neurol; 1976 Dec; 53(3):801-14. PubMed ID: 1001399
    [No Abstract]   [Full Text] [Related]  

  • 35. Critical notes on the specificity of drugs in the study of metabolism and functions of brain monoamines.
    Garattini S; Mennini T
    Int Rev Neurobiol; 1988; 29():259-80. PubMed ID: 3042665
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain.
    Davis JN; Carlsson A
    J Neurochem; 1973 Oct; 21(4):783-90. PubMed ID: 4148239
    [No Abstract]   [Full Text] [Related]  

  • 37. [Behavioral disorders: possible correlation with biogenic cerebral amines].
    Palermo Neto J; Carvalho FV
    Rev Paul Med; 1974 Mar; 83(3):137-44. PubMed ID: 4614362
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies related to the cholinergic influence on the accumulation and disappearance of monoamines in rat brain.
    Bhatnagar SP
    Can J Physiol Pharmacol; 1973 Dec; 51(12):893-9. PubMed ID: 4777240
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on psychotropic drugs. XX. Effects of 1-methyl-5-o-chlorophenyl-7-ethyl-1,2-dihydro-3H-thieno[2,3-e][1,4]diazepin-2-one (Y-6047) on the metabolism of biogenic amines.
    Nakanishi M; Setoguchi M
    Arzneimittelforschung; 1972 Nov; 22(11):1914-8. PubMed ID: 4267010
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlation of brain amine changes with ethanol-induced sleep-time in mice.
    Erickson CK; Matchett JA
    Adv Exp Med Biol; 1975; 59():419-30. PubMed ID: 1180153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.